DexCom

DexCom

Yahoo Finance • 15 hours ago

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5. BURNABY, British Columbia, July 13, 2026--(BUSINESS WIRE)--Dexco... Full story

Yahoo Finance • 5 days ago

Investors’ Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured

Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spend... Full story

Yahoo Finance • 5 days ago

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

SAN DIEGO, July 09, 2026--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call... Full story

Yahoo Finance • 5 days ago

Heald Expands Access to AI-Powered Glucose Intelligence for Over-the-Counter CGM Users

Heald Consumers purchasing Dexcom Stelo or Abbott Lingo through Heald now receive complimentary access to AI-powered glucose insights ALPHARETTA, Ga., July 09, 2026 (GLOBE NEWSWIRE) -- Heald, a digital metabolic health platform, today an... Full story

Yahoo Finance • 6 days ago

Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM

By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued a Notice of Allowance for a patent application which expands the intellectual property protecting the company's continuous blood glucose monitor... Full story

Yahoo Finance • 8 days ago

Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare professionals Omnipod 5 launch in Spain is... Full story

Yahoo Finance • 13 days ago

3 Nasdaq 100 Stocks with Promising Prospects

3 Nasdaq 100 Stocks with Promising Prospects The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dom... Full story

Yahoo Finance • 16 days ago

DexCom, Inc. (DXCM) Further Advances Vision of Glucose Biosensing for All

DexCom, Inc. (NASDAQ:DXCM) is among the Best Healthcare Stocks. On June 23, DexCom, Inc. (NASDAQ:DXCM) announced that the FDA cleared growing use of its Stelo Glucose Biosensor beyond adults for children ages 2 and older who do not use in... Full story

Yahoo Finance • 22 days ago

Piper Sandler Raises its Price Target on DexCom (DXCM)

DexCom, Inc. (NASDAQ:DXCM) is one of the 12 High Quality Stocks to Buy for the Long Term. On June 15, 2026, Piper Sandler analyst Matt O'Brien raised the firm's price target on DexCom, Inc. (NASDAQ:DXCM) to $88 from $75 and maintained an... Full story

Yahoo Finance • 24 days ago

Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?

Key Points Long-term growth matters more than a single quarter. Abbott benefits from multiple healthcare growth trends. Management's outlook could move shares more than earnings.10 stocks we like better than Abbott Laboratories › Abbott... Full story

Yahoo Finance • 26 days ago

Living Longer Is Big Business. These Stocks Will Benefit.

TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion. Continue Reading... Full story

Yahoo Finance • last month

3 Reasons Investors Love DexCom (DXCM)

DexCom trades at $74.63 per share and has stayed right on track with the overall market, gaining 8.3% over the last six months. At the same time, the S&P 500 has returned 6.9%. Is DXCM a buy right now? Find out in our full research report... Full story

Yahoo Finance • last month

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

Diabetes management is evolving rapidly as the industry innovates to treat the more than 40 million Americans with type 1 or type 2 diabetes. Deciding between two leaders in monitoring and treatment, DexCom (NASDAQ:DXCM) and Insulet (NASDA... Full story

Yahoo Finance • 2 months ago

How The DexCom (DXCM) Investment Story Is Shifting With New Guidance And Valuation Resets

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. DexCom’s latest valuation work now centers on a fair value anchor of US$81.64, slightly below th... Full story

Yahoo Finance • 2 months ago

DexCom says some CGM sensors intended for scrap stolen and resold

[Close Up of Woman Wearing Continuous Glucose Monitor CGM Sensor on Arm for Diabetes Tracking] AJITH ACHUTHAN/iStock via Getty Images * DexCom (DXCM [https://seekingalpha.com/symbol/DXCM]) said that some lots of its G7 sensors used with... Full story

Yahoo Finance • 2 months ago

Harnessing medtech market alliances, ŌURA sets IPO plans in motion

ŌURA, creator of its namesake smart ring, has confidentially filed paperwork with the US Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of its common stock. The number of shares to be offered and the... Full story

Yahoo Finance • 2 months ago

Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery

Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund lost 7.14% in the quarter, tied to a 6.75% fall in March due to the War i... Full story

Yahoo Finance • 2 months ago

Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo

Company Logo The wearables in pharma & biotech market is forecasted to grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, at a CAGR of 20.2%. This rapid growth is fueled by advances in biosensor technology, miniaturization, a... Full story

Yahoo Finance • 2 months ago

Jefferies updates Franchise Picks list, adding AMZN, APP, MCD and more

[Wall Street Bull] DNY59/iStock Unreleased via Getty Images Jefferies refreshed its Franchise Picks list Monday. Its equity team added Amazon (AMZN [https://seekingalpha.com/symbol/AMZN]), AppLovin (APP [https://seekingalpha.com/symbol/A... Full story

Yahoo Finance • 2 months ago

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

Key Points Interested in DexCom, Inc.? Here are five stocks we like better. DexCom outlined a long-term growth plan targeting more than 10% annual revenue growth through 2030, along with margin expansion and stronger cash flow. Management... Full story